Westpac Banking Corp Eli Lilly & CO Transaction History

Westpac Banking Corp

$1.49 Trillion
Q3 2024

A detailed history of Westpac Banking Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Westpac Banking Corp holds 28,874 shares of LLY stock, worth $22.5 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares

28,874

Previous 23,054 25.25%

Holding current value

$22.5 Million

Previous $20.9 Billion 22.56%

% of portfolio

1.71%

Previous 1.66%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$772.14 - $960.02 $4.49 Million - $5.59 Million	5,820 Added 25.25%	28,874 $25.6 Billion
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $14.7 Million - $18.5 Million	20,339 Added 749.13%	23,054 $20.9 Billion
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $13.8 Million - $17.2 Million	-18,969 Reduced 87.48%	2,715 $20.9 Billion
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $856,913 - $1.15 Million	-1,447 Reduced 6.26%	21,684 $16.9 Billion
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $9.22 Million - $10.9 Million	-17,565 Reduced 43.16%	23,131 $13.5 Billion
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $4.98 Million - $6.86 Million	11,450 Added 39.15%	40,696 $21.9 Billion
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $51.8 Million - $69.2 Million	-147,552 Reduced 83.46%	29,246 $13.7 Billion
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $6.91 Million - $8.11 Million	22,238 Added 14.39%	176,798 $60.7 Billion
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $1.15 Million - $1.33 Million	-3,562 Reduced 2.25%	154,560 $56.5 Billion
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $2.28 Million - $2.6 Million	7,688 Added 5.11%	158,122 $51.1 Billion
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $2.23 Million - $2.62 Million	-7,992 Reduced 5.04%	150,434 $48.8 Billion
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $10.4 Million - $12.9 Million	-44,275 Reduced 21.84%	158,426 $45.4 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $9.08 Million - $11.3 Million	-40,383 Reduced 16.61%	202,701 $56 Billion
Q3 2021 Oct 27, 2021	SELL	$221.6 - $272.71 $14.2 Million - $17.4 Million	-63,905 Reduced 20.82%	243,084 $56.2 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $8.1 Million - $10.5 Million	-44,837 Reduced 12.74%	306,989 $70.5 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $22.4 Million - $29 Million	136,289 Added 63.23%	351,826 $65.7 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $10.3 Million - $13.6 Million	78,671 Added 57.48%	215,537 $36.4 Million
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $833,600 - $964,210	5,701 Added 4.35%	136,866 $20.3 Million
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $1.9 Million - $2.29 Million	-13,950 Reduced 9.61%	131,165 $21.5 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $1.22 Million - $1.51 Million	10,272 Added 7.62%	145,115 $20.1 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $66,504 - $82,371	-622 Reduced 0.46%	134,843 $17.7 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $1.13 Million - $1.23 Million	-10,604 Reduced 7.26%	135,465 $15.1 Million
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $848,983 - $990,979	7,663 Added 5.54%	146,069 $0
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $2.17 Million - $2.55 Million	-19,456 Reduced 12.32%	138,406 $0
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $1.58 Million - $1.77 Million	14,949 Added 10.46%	157,862 $18.3 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $2.12 Million - $2.64 Million	24,644 Added 20.84%	142,913 $0
Q1 2018 May 01, 2018	BUY	$74.21 - $87.6 $1.81 Million - $2.14 Million	24,400 Added 25.99%	118,269 $0
Q4 2017 Jan 18, 2018	BUY	$81.94 - $87.89 $757,945 - $812,982	9,250 Added 10.93%	93,869 $0
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $6.52 Million - $7.24 Million	84,619	84,619 $0

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Account

Westpac Banking Corp Eli Lilly & CO Transaction History